Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | F13A1 | P00488 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.47 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.47 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.47 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.47 |
| ▸ | ESRRB | O95718 | 1/20 | 0.47 |
| ▸ | ESRRG | P62508 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31540123 | 1.00 | SLC7A5 (0.51) | SLC7A5KDM4EF13A1GAAPLAAT3 | |
| SCHEMBL5076586 | 0.88 | HDAC3 (0.57) | F13A1PLAAT5PLAAT4LTA4HSLC1A1 | |
| SCHEMBL5076581 | 0.88 | HDAC3 (0.57) | F13A1PLAAT5PLAAT4LTA4HSLC1A1 | |
| SCHEMBL29683951 | 0.85 | TRPV1 (0.61) | SLC7A5KDM4EGAATRPV1 | |
| SCHEMBL2819987 | 0.85 | TRPV1 (0.61) | SLC7A5KDM4EGAATRPV1 | |
| SCHEMBL19051470 | 0.84 | CA1 (0.49) | GAALTA4HSLC1A1 | |
| SCHEMBL31369915 | 0.84 | CA1 (0.49) | GAALTA4HSLC1A1 | |
| SCHEMBL8984025 | 0.82 | SLC1A1 (0.42) | LTA4HSLC1A1 | |
| SCHEMBL21341835 | 0.81 | NOD1 (0.50) | SLC7A5LTA4H | |
| SCHEMBL16860742 | 0.80 | L3MBTL1 (0.69) | GAALTA4HTRPV1SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230148070-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2023-05-11 | — | — | US | disclosed |
| US-20230148070-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2023-05-11 | — | — | US | disclosed |
| WO-2021209345-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230148070-A1 | AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS | GLUL, TAS2R5, ARGLU1 | SLC7A5 82/4885KDM4E 1252/4885F13A1 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.